Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.3) replacing v3.6.2, indicating a minor software update. No study details or content appear affected by this change.
    Difference
    0.1%
    Check dated 2026-07-04T08:11:13.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page revision was updated from `v3.6.0` to `v3.6.2`, indicating a backend update; no substantive study details appear to be affected.
    Difference
    0.1%
    Check dated 2026-06-27T03:26:16.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now shows that recruitment is closed with the message 'No longer looking for participants'. New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added and the page revision was updated to v3.6.0, reflecting navigation refinements and a new version release.
    Difference
    0.4%
    Check dated 2026-06-12T17:32:01.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's documentation or formatting.
    Difference
    0.1%
    Check dated 2026-06-05T13:51:41.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.5.3 to v3.5.4, reflecting a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-05-15T05:53:32.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    This update reflects a change in the ClinicalTrials.gov page revision/version number from v3.5.2 to v3.5.3, indicating a site release rather than a modification to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:48:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.